Organogenesis Holdings, Inc. (ORGO)
3.915
-0.08
(-1.88%)
USD |
NASDAQ |
Feb 23, 16:00
3.915
0.00 (0.00%)
After-Hours: 19:59
Organogenesis Holdings EPS Diluted (Quarterly) : 0.111 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0704 |
| Celularity, Inc. | -0.8758 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 21.57M |
| Revenue (Quarterly) | 150.86M |
| Total Expenses (Quarterly) | 129.30M |
| Enterprise Value | 613.67M |
| Gross Profit Margin (Quarterly) | 71.34% |
| Profit Margin (Quarterly) | 14.30% |
| Earnings Yield | -2.51% |
| Operating Earnings Yield | 0.36% |
| Normalized Earnings Yield | -1.073 |